172 related articles for article (PubMed ID: 6321753)
1. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells.
Reagan KJ; Goldberg B; Crowell RL
J Virol; 1984 Mar; 49(3):635-40. PubMed ID: 6321753
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.
Crowell RL; Field AK; Schleif WA; Long WL; Colonno RJ; Mapoles JE; Emini EA
J Virol; 1986 Feb; 57(2):438-45. PubMed ID: 3003376
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.
Hsu KH; Lonberg-Holm K; Alstein B; Crowell RL
J Virol; 1988 May; 62(5):1647-52. PubMed ID: 2451756
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
[TBL] [Abstract][Full Text] [Related]
5. Attempts to purify a second cellular receptor for a coxsackievirus B3 variant, CB3-RD from HeLa cells.
Mohanty JG; Crowell RL
Virus Res; 1993 Sep; 29(3):305-20. PubMed ID: 8237113
[TBL] [Abstract][Full Text] [Related]
6. Purification of a HeLa cell receptor protein for group B coxsackieviruses.
Mapoles JE; Krah DL; Crowell RL
J Virol; 1985 Sep; 55(3):560-6. PubMed ID: 2991580
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3.
Lindberg AM; Crowell RL; Zell R; Kandolf R; Pettersson U
Virus Res; 1992 Jul; 24(2):187-96. PubMed ID: 1326828
[TBL] [Abstract][Full Text] [Related]
8. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.
Pan J; Narayanan B; Shah S; Yoder JD; Cifuente JO; Hafenstein S; Bergelson JM
J Virol; 2011 Jul; 85(14):7436-43. PubMed ID: 21561916
[TBL] [Abstract][Full Text] [Related]
9. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.
Bergelson JM; Modlin JF; Wieland-Alter W; Cunningham JA; Crowell RL; Finberg RW
J Infect Dis; 1997 Mar; 175(3):697-700. PubMed ID: 9041347
[TBL] [Abstract][Full Text] [Related]
10. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
Polacek C; Ekström JO; Lundgren A; Lindberg AM
Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
[TBL] [Abstract][Full Text] [Related]
11. Identification of the integrin VLA-2 as a receptor for echovirus 1.
Bergelson JM; Shepley MP; Chan BM; Hemler ME; Finberg RW
Science; 1992 Mar; 255(5052):1718-20. PubMed ID: 1553561
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
[TBL] [Abstract][Full Text] [Related]
13. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
Shafren DR; Williams DT; Barry RD
J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
[TBL] [Abstract][Full Text] [Related]
14. Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells.
Carson SD; Kim KS; Pirruccello SJ; Tracy S; Chapman NM
J Gen Virol; 2007 Nov; 88(Pt 11):3031-3038. PubMed ID: 17947527
[TBL] [Abstract][Full Text] [Related]
15. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
16. A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.
Gullberg M; Tolf C; Jonsson N; Polacek C; Precechtelova J; Badurova M; Sojka M; Mohlin C; Israelsson S; Johansson K; Bopegamage S; Hafenstein S; Lindberg AM
J Virol; 2010 Jun; 84(12):5868-79. PubMed ID: 20375176
[TBL] [Abstract][Full Text] [Related]
17. Genome of coxsackievirus B3.
Lindberg AM; Stålhandske PO; Pettersson U
Virology; 1987 Jan; 156(1):50-63. PubMed ID: 3027968
[TBL] [Abstract][Full Text] [Related]
18. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.
Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC
Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus IgM detection: specificity of mu-antibody-capture radioimmunoassays using virions and procapsids of Coxsackie B virus.
Frisk G; Nilsson E; Ehrnst A; Diderholm H
J Virol Methods; 1989; 24(1-2):191-202. PubMed ID: 2547815
[TBL] [Abstract][Full Text] [Related]
20. [The role of the neonatal FC receptor in the uncoating of echoviruses and coxsackievirus A9.].
Usoltseva PS; Alimov AV; Rezaykin AV; Sergeev AG; Novoselov AV
Vopr Virusol; 2019; 64(3):132-139. PubMed ID: 31622060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
